Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

7.5%

39 terminated/withdrawn out of 519 trials

Success Rate

84.1%

-2.4% vs industry average

Late-Stage Pipeline

12%

60 trials in Phase 3/4

Results Transparency

3%

7 of 206 completed trials have results

Key Signals

22 recruiting7 with results12 terminated27 withdrawn

Enrollment Performance

Analytics

N/A
204(64.6%)
Phase 4
41(13.0%)
Phase 2
35(11.1%)
Phase 3
19(6.0%)
Phase 1
12(3.8%)
Early Phase 1
5(1.6%)
316Total
N/A(204)
Phase 4(41)
Phase 2(35)
Phase 3(19)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (519)

Showing 20 of 519 trials
NCT02083835Recruiting

PAIN OUT: Improvement in Postoperative PAIN OUTcome

Role: collaborator

NCT05137119Phase 4Recruiting

Staphylococcus Aureus Network Adaptive Platform Trial

Role: collaborator

NCT07067619Not ApplicableRecruiting

Pain Acceptance Training in Patients Experiencing Emotional Distress and Somatic Symptoms: Examination of Dialectical Thinking as a Mediating Factor

Role: collaborator

NCT06902675Active Not Recruiting

Artificial Intelligence as a Decision Making Tool in Emergency Department

Role: lead

NCT07384013Not ApplicableRecruiting

Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs

Role: lead

NCT07328308Not ApplicableNot Yet Recruiting

Delayed Surveillance Colonoscopy Following Piecemeal EMR

Role: lead

NCT06622902Not ApplicableRecruiting

Influence of Flow Rate Change on CO2 Levels During High Flow Nasal Ventilation (HFNV) in Preterm Infants.

Role: lead

NCT04581304Not ApplicableActive Not Recruiting

The Use of Bio-Oss Collagen for Sinus Augmentation Using the Transcrestal Approach.

Role: lead

NCT07131163Recruiting

Real World Stage II-III NSCLC Patients Receiving Neoadjuvant Chemo-immunotherapy and no Surgical Resection

Role: collaborator

NCT03766022Not ApplicableCompleted

Effect of Heavy Smoking on Hard and Soft Tissue Parameters Prospective Clinical Trial

Role: lead

NCT05833165Recruiting

Feasibility of Integrating Homeopathic Approach in a Comprehensive Cancer Center

Role: lead

NCT05922124Phase 4Recruiting

Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii

Role: lead

NCT03671967Phase 4Recruiting

PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)

Role: lead

NCT05355350Phase 4Withdrawn

PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections

Role: lead

NCT06946940Phase 2Recruiting

Biosignature of the Response to Treatment With Cannabis Oil in Individuals With Fibromyalgia

Role: lead

NCT06941285Completed

Montreal Cognitive Assessment Index Following MRI Guided Focused Ultrasound Thalamotomy

Role: lead

NCT05599347Phase 2Recruiting

Pre-treatment With Azithromycin to Reduce Immunogenicity to to Anti-TNF Agents in Patients With Crohn's Disease

Role: lead

NCT05316740Active Not Recruiting

Vaginal Microbiome and the Development of Vulvovaginal Graft Versus Host Disease

Role: collaborator

NCT06235749Not ApplicableRecruiting

Administration Of Calcium Gluconate for The Reduction of Blood Loss During Elective Cesarean Delivery

Role: lead

NCT01067287Phase 2Active Not Recruiting

Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation

Role: collaborator